Table 1.
Control group (n = 40) | Acromegaly group (n = 40) | p value | |
---|---|---|---|
Age, year, mean ± SD | 47.3 ± 7.2 | 47.7 ± 7.8 | 0.502 |
Gender male/female, n (%) | 24 (60.0)/16 (40.0) | 16 (40.0)/24 (60.0) | 0.117 |
Disease duration, year, mean ± SD | 11.0 ± 5.5 | ||
IGF-1 level, ng/ml, mean ± SD | 208.5 ± 84.1 | ||
IOP, mmHg, mean ± SD | 16.0 ± 1.6 | 15.7 ± 1.9 | 0.815 |
BCVA, logMAR mean ± SD | 0.00 ± 0.00 | 0.00 ± 0.00 | N/A |
Spherical equivalent, D, mean ± SD | 0.31 ± 0.65 | 0.28 ± 0.83 | 0.822 |
Axial length, mm, mean ± SD | 22.7 ± 0.5 | 22.7 ± 0.7 | 0.502 |
BCVA best corrected visual acuity, IOP intraocular pressure, IGF-1 insulin-like growth factor-1, D diopter, mm milimeter.